World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
87
Citations
29177
World Ranking
1207
National Ranking
162

Overview

Teruhiko Yoshida is affiliated with the National Cancer Research Institute, UK, based in the United Kingdom. Their research spans multiple fields within medicine and biochemistry, genetics, and molecular biology, with a substantial focus on molecular biology, nephrology, genetics, oncology, and epidemiology.

Their publication record includes studies featured in notable venues such as the Journal of the American Society of Nephrology, bioRxiv (Cold Spring Harbor Laboratory), Kidney International Reports, Journal of Cancer Research and Clinical Oncology, and Scientific Reports.

Among recent papers, Teruhiko Yoshida has contributed to research on diverse topics, with selected works including:

  • "Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes" (2020, EBioMedicine)
  • "Urine Single-Cell RNA Sequencing in Focal Segmental Glomerulosclerosis Reveals Inflammatory Signatures" (2021, Kidney International Reports)
  • "Genome-wide association meta-analysis identifies GP2 gene risk variants for pancreatic cancer" (2020, Nature Communications)
  • "NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease" (2023, Journal of Biological Chemistry)
  • "Aberrant DNA methylation results in altered gene expression in non-alcoholic steatohepatitis-related hepatocellular carcinomas" (2020, Journal of Cancer Research and Clinical Oncology)

Frequent co-authors in Teruhiko Yoshida's network include:

  • Jeffrey B. Kopp
  • Avi Z. Rosenberg
  • Khun Zaw Latt
  • Shashi Shrivastav
  • Cheryl A. Winkler

The work covers a range of key topics, predominantly:

  • Renal Diseases and Glomerulopathies
  • Epigenetics and DNA Methylation
  • Renal and related cancers
  • Cancer Genomics and Diagnostics
  • Single-cell and spatial transcriptomics
  • PARP inhibition in cancer therapy
  • RNA modifications and cancer

Teruhiko Yoshida's research integrates approaches in genetics, molecular biology, and oncology to address questions related to renal diseases and cancer. The blend of large-scale genetic studies, epigenetic analysis, and transcriptomics underlines a multidisciplinary approach within their work.

Best Publications

  • International network of cancer genome projects

    Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker

  • Erratum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer (Nature Genetics (2009) 41 (991-995))

    Xifeng Wu;Yuanqing Ye;Lambertus A. Kiemeney;Patrick Sulem

  • KIF5B-RET fusions in lung adenocarcinoma.

    Takashi Kohno;Hitoshi Ichikawa;Yasushi Totoki;Kazuki Yasuda

  • Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus.

    Kazuki Yasuda;Kazuaki Miyake;Yukio Horikawa;Kazuo Hara

  • Epidermal Growth Factor Receptor Gene Mutations and Increased Copy Numbers Predict Gefitinib Sensitivity in Patients With Recurrent Non–Small-Cell Lung Cancer

    Toshimi Takano;Yuichiro Ohe;Hiromi Sakamoto;Koji Tsuta

  • Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases

    Kazuyoshi Ishigaki;Kazuyoshi Ishigaki;Masato Akiyama;Masahiro Kanai;Masahiro Kanai;Atsushi Takahashi

  • Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer.

    Hiromi Sakamoto;Kimio Yoshimura;Norihisa Saeki

  • The acceleration of cosmic-ray protons in the supernova remnant RX J1713.7–3946

    R. Enomoto;T. Tanimori;T. Naito;T. Yoshida

  • cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity.

    Masanori Taira;Teruhiko Yoshida;Kiyoshi Miyagawa;Hiromi Sakamoto

  • K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes.

    Yutaka Hattori;Hiroki Odagiri;Hiroshi Nakatani;Kiyoshi Miyagawa

  • Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa.

    Hiromi Sakamoto;Midori Mori;Masanori Taira;Teruhiko Yoshida

  • Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *28.

    Hironobu Minami;Kimie Sai;Mayumi Saeki;Yoshiro Saito

  • Genomic sequence of hst, a transforming gene encoding a protein homologous to fibroblast growth factors and the int-2-encoded protein.

    Teruhiko Yoshida;Kiyoshi Miyagawa;Hiroki Odagiri;Hiromi Sakamoto

  • High-resolution characterization of a hepatocellular carcinoma genome

    Yasushi Totoki;Kenji Tatsuno;Shogo Yamamoto;Yasuhito Arai

  • Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue.

    Yokota J;Yamamoto T;Miyajima N;Toyoshima K

  • Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study

    Kuniko Sunami;Hitoshi Ichikawa;Takashi Kubo;Mamoru Kato

  • UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer.

    Kimie Sai;Mayumi Saeki;Yoshiro Saito;Shogo Ozawa

  • Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer

    Xifeng Wu;Yuanqing Ye;Lambertus A. Kiemeney;Patrick Sulem

  • Distinctive expression and function of four GSDM family genes (GSDMA-D) in normal and malignant upper gastrointestinal epithelium.

    Norihisa Saeki;Takebumi Usui;Kazuhiko Aoyagi;Dal Ho Kim

  • Liposome-mediated in Vivo Gene Transfer of Antisense K-ras Construct Inhibits Pancreatic Tumor Dissemination in the Murine Peritoneal Cavity

    Kazunori Aoki;Teruhiko Yoshida;Takashi Sugimura;Masaaki Terada

Frequent Co-Authors

Hiromi Sakamoto
Hiromi Sakamoto National Cancer Research Institute, UK
Masaaki Terada
Masaaki Terada National Cancer Research Institute, UK
Jun-ichi Sawada
Jun-ichi Sawada University of Shizuoka
Yoshiro Saito
Yoshiro Saito Tohoku University
Nagahiro Saijo
Nagahiro Saijo AstraZeneca (United Kingdom)
Atsushi Ohtsu
Atsushi Ohtsu Juntendo University
Takashi Sugimura
Takashi Sugimura National Cancer Centre
Shogo Ozawa
Shogo Ozawa Iwate Medical University
Yuichiro Ohe
Yuichiro Ohe National Cancer Centre
Tomohide Tamura
Tomohide Tamura St. Luke's International Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring genetics opens the door to a wide range of related online degrees and career options. Many students interested in genetics pursue specialty fields that can be studied online, offering flexibility for busy schedules. For example, online schools for medical billing and coding provide an entry into healthcare data management, which is essential in genetics research and clinical settings.

Students seeking to move quickly into professional roles may benefit from accelerated programs. These programs allow you to earn credentials faster, expediting your path to employment or further study in genetics and related fields.

Budget-conscious learners can start their studies with the cheapest self-paced online college options. Self-paced courses let you balance your studies with other commitments while controlling costs.

Additionally, those looking to minimize upfront expenses can choose from no application fee universities. This makes it easier to apply to multiple programs and find the best fit for your career ambitions in genetics and its many interdisciplinary areas.

Best Scientists Citing Teruhiko Yoshida

Trending Scientists

Recently Published Articles